CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.

Wei LiShujun XiaAnna AronovaIrene M MinAkanksha VermaTheresa ScognamiglioKatherine D GrayTimothy M UllmannHeng LiangMaureen D MooreOlivier ElementoRasa ZarnegarThomas J Fahey

Published in: Journal of surgical oncology (2018)

CHL1 expression may represent a novel and useful prognostic biomarker to distinguish HCC from benign Hürthle cell disease.

Keyphrases

poor prognosis
single cell
cell therapy
long non coding rna
mesenchymal stem cells